169692-94-8

Basic information

• Product Name: 2-METHYL-2-PROPANYL 3,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRROLE-2(1H)-CARBOXYLATE
• Synonyms: tert-butyl 4,5-dihydropyrrolo[3,4-c]pyrrole-2(1H,3H,4H)-carboxylate;tert-Butyl 3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate
• CAS NO: 169692-94-8
• Molecular Formula: C₁₁H₁₈N₂O₂
• Molecular Weight: 210.27282
• EINECS: -0
• Mol File: 169692-94-8.mol

Chemical Properties

• Boiling Point: 322.1±42.0 °C(Predicted)
• Appearance: /
• Density: 1.14±0.1 g/cm3(Predicted)
• PKA: 9.18±0.20(Predicted)
• CAS DataBase Reference: 2-METHYL-2-PROPANYL 3,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRROLE-2(1H)-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-METHYL-2-PROPANYL 3,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRROLE-2(1H)-CARBOXYLATE(169692-94-8)
• EPA Substance Registry System: 2-METHYL-2-PROPANYL 3,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRROLE-2(1H)-CARBOXYLATE(169692-94-8)

Safety Data

• Hazardous Substances Data: 169692-94-8(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 135325-05-2 1,2,3,4,5,6-hexahydropyrrolo<3,4-c>pyrrole dihydrobromide 

Relevant articles and documents

2-HETEROARYL-PYRROLO[3,4-C]PYRROLE DERIVATIVES AND THEIR USE AS SCD INHIBITORS

The invention relates to heterocyclic derivatives of formula I wherein R, R1, A, B, D, M, L and n are as defined herein, or their physiologically compatible salts, their pharmaceutical compositions and their uses as SCD1 inhibitors

HETEROCYCLIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE

Heterocyclic compounds of structural formula I are inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD). The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease; atherosclerosis; obesity; diabetes; neurological disease; Metabolic Syndrome; insulin resistance; cancer, liver steatosis; and non-alcoholic steatohepatitis.

NICOTINIC ACETYLCHOLINE RECEPTORSUB-TYPE SELECTIVE AMIDES OF DIAZABICYCLOALKANES

Compounds, pharmaceutical compositions including the compounds, and methods of preparation and use thereof are disclosed. The compounds are amide compounds which can be prepared from certain heteoraryl carboxylic acids and certain diazabicycloalkanes. The

Modulators of chemokine receptor activity

Chemokine receptor antagonists, in particular, bicyclic diamine compounds of Formula (I) that act as antagonists of chemokine CCR2 and CCR3 receptors including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation are described herein.